Business Context and Reporting Period
Company: Myriad Genetics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 31, 2025
Event: Entry into a Material Definitive Agreement (Credit Agreement).
Key Financial Metrics and Debt Structure
This filing details a new debt facility rather than reporting operational financial results (revenue, profit, or cash flow) for a specific period.
- Total Credit Facility: $200 million term loan.
- Initial Loan: $125 million funded on the Closing Date (July 31, 2025).
- Delayed Draw Loans: Up to $75 million available at the Company's election on or prior to June 30, 2027.
- Maturity Date: July 31, 2030.
- Interest Rate: One-month SOFR Rate (floored at 2.50%) plus an applicable margin of 6.50%.
- Collateral: Secured by substantially all assets of the Company and its material subsidiaries.
- Use of Proceeds: Working capital, general corporate purposes, and refinancing existing indebtedness.
Material Changes and Covenants
The Company has entered into a new secured credit facility, representing a material change in its capital structure and debt obligations.
- Revenue Covenant: The Company must maintain a minimum trailing twelve-month revenue of $615 million as of December 31, 2025. This threshold increases quarterly to $974 million beginning December 31, 2029.
- Amortization: Commencing September 30, 2029, the Company must make scheduled principal payments equal to 2.50% of the unpaid principal amount outstanding on the fourth anniversary of the Closing Date.
- Restrictions: The agreement includes customary negative covenants limiting the ability to incur additional liens or indebtedness, dispose of assets, make investments, or enter into speculative hedging arrangements.
Outlook, Risks, and Contingencies
Management Commentary: The proceeds are intended to support working capital and refinance existing debt. The filing incorporates a press release regarding the agreement.
Risks and Contingencies:
- Events of Default: Includes nonpayment, covenant breaches (including the revenue test), cross-defaults to other material indebtedness, bankruptcy, insolvency, material judgments, and change of control.
- Acceleration: Upon an event of default, all outstanding principal, interest, and premiums may become immediately due and payable.
- Prepayment: Voluntary prepayments are subject to a repayment premium.
Investor Verification Checklist
- Verify the Company's current trailing twelve-month revenue against the $615 million covenant threshold required by December 31, 2025.
- Review the specific terms of the "repayment premium" for voluntary prepayments in the full Credit Agreement (Exhibit 10.1).
- Assess the impact of the new interest rate structure (SOFR + 6.50%) on future interest expense compared to refinanced debt.
- Confirm the status of existing indebtedness being refinanced and the net reduction in total leverage.
- Examine the list of "Guarantors" and the scope of assets pledged under the Security Agreement (Exhibit 10.2).